Coming Soon – A1AT Lateral Flow Assay. Mologic is pleased to announce that the next product to be launched will be an A1AT lateral flow assay. This will be for the quantitative determination of Alpha-1 antitrypsin (A1AT) concentration in urine and serum samples. Watch this space for more details. By Mologic|2018-11-29T09:34:59+00:00August 18th, 2015| Share This Post FacebookTwitterLinkedIn Related Posts Mologic’s COVID-19 Rapid Antigen Self-Test Selected by NIH for RADx Initiative Funding Aptamer Group and Mologic enter commercial partnership to develop aptamer-based SARS-CoV-2 rapid antigen test Avacta and Mologic announce commercial partnership Mologic Receives CE Mark Approval for Professional-Use COVID-19 Rapid Antigen Test Mologic and the University of Liverpool collaborate to develop a rapid diagnostic test for common agricultural parasite Leave A Comment Cancel replyComment By using this form you agree with the storage and handling of your data by this website. *
Leave A Comment